Citigroup
ATHN

Citigroup’s Athenahealth, Inc. ATHN Stock Holding History

Citigroup’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,300
Closed -$304K – 7978
2018
Q4 		$304K Buy
2,300
+1,400
+156% +$179K ﹤0.01% 4613
2018
Q3 		$120K Sell
900
-7,100
-89% -$1.06M ﹤0.01% 5729
2018
Q2 		$1.27M Buy
8,000
+6,300
+371% +$934K ﹤0.01% 3105
2018
Q1 		$243K Sell
1,700
-12,000
-88% -$1.64M ﹤0.01% 4764
2017
Q4 		$1.82M Buy
13,700
+7,100
+108% +$907K ﹤0.01% 2766
2017
Q3 		$821K Buy
6,600
+3,100
+89% +$427K ﹤0.01% 3589
2017
Q2 		$492K Sell
3,500
-51,700
-94% -$6.46M ﹤0.01% 4004
2017
Q1 		$6.22M Buy
55,200
+54,000
+4,500% +$6.29M 0.01% 1489
2016
Q4 		$126K Buy
1,200
+500
+71% +$53.7K ﹤0.01% 5632
2016
Q3 		$88K Sell
700
-1,300
-65% -$165K ﹤0.01% 5292
2016
Q2 		$276K Buy
2,000
+300
+18% +$39.7K ﹤0.01% 4202
2016
Q1 		$236K Buy
1,700
+1,400
+467% +$192K ﹤0.01% 4930
2015
Q4 		$48K Sell
300
-100
-25% -$15.4K ﹤0.01% 5973
2015
Q3 		$53K Buy
+400
New +$52.2K ﹤0.01% 5405

Citigroup's ATHN Position: Q1 2019 in Review

Citigroup sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 333,479 shares — an estimated $44M sold.

Citigroup first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $44M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Citigroup reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citigroup sold 333,479 Athenahealth, Inc. shares in Q1 2019, an estimated $44M.
  • Citigroup first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Citigroup's Athenahealth, Inc. position peaked at $44M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.